Sign In
Sign Up
Two Blokes
Bristol Myers Squibb and Bain Capital Form New Immunology Company
click to rate
Posted by
Two Blokes
Jul 28
- Filed in
Stock
- 1 view
The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.
